Technical Analysis for BLPH - Bellerophon Therapeutics, Inc.

Grade Last Price % Change Price Change
D 0.06 13.80% 0.01
BLPH closed up 13.8 percent on Monday, March 18, 2024, on 9 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
Earnings due: Mar 29
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Crossed Above 50 DMA Bullish 0.00%
MACD Bullish Centerline Cross Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Wide Range Bar Range Expansion 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

   Recent Intraday Alerts

Alert Time
Rose Above 20 DMA about 16 hours ago
Rose Above 50 DMA about 16 hours ago
Rose Above 10 DMA about 16 hours ago
60 Minute Opening Range Breakout about 16 hours ago
Rose Above Upper Bollinger Band about 16 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Bellerophon Therapeutics LLC, a clinical-stage therapeutics company, focuses on the development of various products for the treatment of cardiopulmonary and cardiac diseases. Its product candidates include INOpulse for the treatment of pulmonary arterial hypertension, as well as to treat pulmonary hypertension associated with chronic obstructive pulmonary diseases; and bioabsorbable cardiac matrix, a medical device for the prevention of congestive heart failure. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics LLC in January 2014. Bellerophon Therapeutics LLC was founded in 2009 and is based in Hampton, New Jersey.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Cardiovascular Disease Hypertension Heart Failure Chronic Obstructive Pulmonary Disease Respiratory Diseases Pulmonary Arterial Hypertension Pulmonary Disease Aging Associated Diseases Pulmonology Congestive Heart Failure Pulmonary Hypertension Cardiovascular System Oab Cardiac Diseases

Is BLPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.58
52 Week Low 0.029
Average Volume 76,960
200-Day Moving Average 0.37
50-Day Moving Average 0.06
20-Day Moving Average 0.05
10-Day Moving Average 0.05
Average True Range 0.01
RSI (14) 53.70
ADX 19.14
+DI 22.43
-DI 8.74
Chandelier Exit (Long, 3 ATRs) 0.04
Chandelier Exit (Short, 3 ATRs) 0.06
Upper Bollinger Bands 0.06
Lower Bollinger Band 0.05
Percent B (%b) 0.93
BandWidth 16.17
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0004
Fundamentals Value
Market Cap 696.03 Thousand
Num Shares 12.2 Million
EPS -0.89
Price-to-Earnings (P/E) Ratio -0.06
Price-to-Sales 0.12
Price-to-Book 0.21
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.07
Resistance 3 (R3) 0.07 0.07 0.07
Resistance 2 (R2) 0.07 0.06 0.07 0.07
Resistance 1 (R1) 0.06 0.06 0.06 0.06 0.07
Pivot Point 0.06 0.06 0.06 0.06 0.06
Support 1 (S1) 0.05 0.05 0.05 0.05 0.04
Support 2 (S2) 0.04 0.05 0.04 0.04
Support 3 (S3) 0.04 0.04 0.04
Support 4 (S4) 0.04